K
KnowMBAAdvisory
OperationsAdvanced9 min read

Contract Manufacturing Strategy

Contract Manufacturing Strategy is the discipline of deciding what to make in-house versus outsource to a contract manufacturer (CM) โ€” and how to structure the relationship when you outsource. The two big choices: (1) the make-vs-buy decision per component/product (driven by strategic differentiation, IP risk, capital intensity, scale economics, and demand volatility), and (2) the engagement model when you do outsource โ€” turnkey (CM owns sourcing, manufacturing, and logistics), consigned (you own the bill-of-materials, CM provides labor and capacity), or hybrid. Apple, Nike, and Cisco built their valuations on contract manufacturing: they design and own the brand, the IP, the customer relationship, and the scale economics โ€” but outsource the capital-intensive factory work. KnowMBA POV: in-house manufacturing only makes sense when (a) the process IS your differentiation (Tesla battery cells, TSMC fabs), (b) volumes are too low to attract a CM, or (c) IP leakage risk is existential. For everything else, a top-tier CM beats your in-house factory on cost, scale, and flexibility โ€” provided you negotiate the relationship right.

Also known asContract ManufacturingCM StrategyEMS StrategyOutsourced ManufacturingMake-vs-Buy

The Trap

The trap is treating CMs as commodity vendors when they're actually capability partners. Companies that switch CMs every 2-3 years for marginal price savings give up the cumulative learning curve, custom tooling, and engineering integration that compound over time. Conversely, the opposite trap is over-dependency: outsourcing 100% of manufacturing to a single CM (especially in a single geography) creates existential exposure. Apple keeps Foxconn AND Pegatron AND Wistron qualified. The third trap is IP leakage โ€” many companies have outsourced manufacturing to a CM, only to find the CM (or its parent) launching a competing product 2 years later using the design knowledge they acquired. Always assume the CM will eventually compete with you, and structure IP, tooling ownership, and supplier exclusivity accordingly.

What to Do

Run a structured CM strategy: (1) Make-vs-buy framework: rate each product/component on strategic value ร— scale economics ร— capital intensity ร— IP risk. Strategic + low capital = make. Non-strategic + high capital = buy. (2) CM selection: shortlist 3-5 CMs against capability, financial health, geographic footprint, customer concentration (don't pick a CM where you'd be 80% of revenue OR <5% of revenue), and reference checks. (3) Contract structure: define IP ownership clearly, set tooling ownership (ideally yours), build in audit rights, second-source clauses, and exit ramps. (4) Operational integration: embed your engineers at the CM, run weekly production reviews, and treat the CM team like an extension of your ops team. (5) Maintain a credible alternative: even with one primary CM, keep a second CM warm with at least 10-20% of volume to preserve negotiating leverage and disaster recovery.

Formula

Make-vs-Buy: Make if [In-house Total Cost < CM Total Cost] AND [Strategic Differentiation > Threshold] OR [IP Leakage Risk = Existential]. CM Total Cost = Unit Price + IP Risk Premium + Switching Cost + Coordination Overhead.

In Practice

Apple's Foxconn relationship is the canonical case of contract manufacturing done at industrial scale. Apple designs the iPhone in Cupertino, owns all IP and tooling, prepays Foxconn billions in capacity reservations, and embeds hundreds of Apple operations engineers inside Foxconn's Zhengzhou and Shenzhen plants. Apple owns the consumer relationship, the OS, the chip design (M-series, A-series), the marketing โ€” but Foxconn owns the assembly labor and operates plants employing 1.4M+ workers globally. The structure lets Apple scale production from zero to 200M+ units annually for new iPhone launches without owning a single factory. Critically, Apple keeps Pegatron and Wistron qualified for ~30% of volume (and is shifting ~14% to India via Tata) so Foxconn can never hold Apple hostage. When Foxconn's Zhengzhou facility was disrupted by COVID lockdowns in late 2022, Apple shifted volume to Pegatron and Wistron within weeks โ€” a flexibility only possible because Apple maintained multi-CM optionality.

Pro Tips

  • 01

    Own the tooling. The molds, jigs, fixtures, and test equipment specific to your product should be on YOUR balance sheet (or at minimum, contractually transferable on 30 days notice). Without tooling ownership, switching CMs takes 6-12 months and tens of millions in retooling. With tooling ownership, you can shift production in weeks.

  • 02

    Don't be 80%+ of any CM's revenue, and don't pick a CM where you'd be <5%. The 80% case means the CM rises and falls with you (existential mutual dependence โ€” but also gives them political leverage if they're failing). The <5% case means you're a low-priority customer who gets the C-team and the leftover capacity. Aim for 10-30% of CM revenue: meaningful but not existential.

  • 03

    Pay capacity reservation fees. Apple, Cisco, and HP routinely pre-pay CMs for guaranteed capacity (often hundreds of millions). The CM uses your prepayment to fund expansion; you get priority access during shortages. Companies that don't reserve capacity end up scrambling for slots at 2-3x spot pricing when demand surges.

Myth vs Reality

Myth

โ€œContract manufacturing always saves moneyโ€

Reality

On unit cost alone, scale CMs typically beat in-house โ€” but coordination overhead, IP risk premium, switching cost amortization, and quality monitoring add 10-25% of nominal price savings back. The right comparison isn't unit cost vs unit cost; it's Total Cost of Ownership including hidden coordination costs. For low-volume or highly customized products, in-house manufacturing often wins on TCO.

Myth

โ€œIf we outsource, we lose the manufacturing capability foreverโ€

Reality

Apple, Cisco, and Nike outsource manufacturing AND maintain world-class operations capability โ€” they staff hundreds of operations engineers who design processes, embed at CM facilities, and drive yield improvements. The capability you lose is FACTORY OPERATIONS; the capability you keep is MANUFACTURING ENGINEERING. The latter is more strategic anyway.

Try it

Run the numbers.

Pressure-test the concept against your own knowledge โ€” answer the challenge or try the live scenario.

๐Ÿงช

Scenario Challenge

You're CEO of a hardware startup at $200M revenue, growing 80% YoY. Your in-house factory in Texas is at 95% capacity. Options: (1) Build a $150M second factory (24-month build, $30M annual ops cost), or (2) Sign a 5-year contract with a major CM in Vietnam (no capex, 8% lower unit cost, but you'd own ~12% of the CM's revenue). Your investor board is split.

Real-world cases

Companies that lived this.

Verified narratives with the numbers that prove (or break) the concept.

๐Ÿ“ฑ

Apple โ†” Foxconn

2007-present

success

Apple's contract manufacturing model with Foxconn is the largest and most studied CM relationship in history. Apple owns design, IP, OS, marketing, and consumer relationship. Foxconn owns assembly labor โ€” 1.4M+ workers across China and Asia building iPhones, iPads, and Macs. Apple prepays billions for capacity, embeds hundreds of operations engineers at Foxconn plants, and owns all custom tooling. Critically, Apple maintains Pegatron and Wistron at ~30% volume share to preserve optionality. When Foxconn's Zhengzhou plant was disrupted in late 2022 (COVID lockdowns), Apple shifted volume within weeks โ€” a flexibility that depended on multi-CM strategy and tooling ownership.

Foxconn Apple-Dedicated Workforce

~700K-1M (peak)

Apple Capacity Pre-payments

$10-15B annually

Secondary CM Volume Share

~30% (Pegatron/Wistron/Tata)

iPhone Annual Production Capacity

200M+ units

Outsource capital-intensive operations, retain IP and consumer relationship, never let any single CM exceed ~70% of volume. Apple's $3T market cap was built on contract manufacturing done with discipline and optionality.

Source โ†—

Decision scenario

The Single-CM Concentration Decision

You're VP Operations at a $400M consumer electronics company. 95% of your manufacturing is at one CM in Shenzhen. They've been excellent โ€” quality, cost, responsiveness โ€” for 6 years. They're proposing a 5% volume rebate if you commit to 100% with them for the next 3 years. Your board is asking why you'd say no to a 'free' $20M.

Annual CM Spend

$400M

Current CM Volume Share

95%

Secondary CM Volume

5% (Vietnam, qualified)

Proposed Rebate

5% ($20M) for 100% commitment

Switching Cost (full)

~$25M, 9-12 months

01

Decision 1

Year 2 of the exclusive contract: US-China trade tensions escalate. The Shenzhen CM raises prices 8% citing 'tariff and labor cost pressures' and asks for an additional 4% to maintain priority allocation as their Apple-related demand surges. You have no qualified secondary CM (you let it go to grab the $20M rebate). Switching now would take 12+ months and ~$30M.

Take the rebate โ€” sign the 100% commitment. The CM has been reliable for 6 years.Reveal
By year 2, you've taken $40M in rebates. But the CM has raised prices 12% cumulatively (no leverage to push back), reduced your priority during their capacity shortage, and EOL'd a custom SKU for being 'sub-scale' for them. Net cost increase over 3 years: ~$60M. Net of $40M rebates: โˆ’$20M vs the alternative. Worse, you face a captive-supplier dynamic for the next 2-3 years until you can re-qualify a secondary.
Rebates Captured: +$40M over 3 yearsCumulative Price Increases: +12% (~$60M)Optionality: 100% concentration, no leverage
Decline the 100% commitment. Counter-propose: 3% rebate for 80% commitment, with secondary CM growing to 20%.Reveal
You give up $8M annually in rebates ($24M over 3 years). But when prices rise in year 2, you have a credible alternative โ€” you grow secondary CM to 35% and the primary CM rolls back the price increase to keep their share. The optionality saved ~$45M in the same scenario. Net of foregone rebates: +$21M vs the all-in alternative, and you preserved long-term flexibility. The board now understands why you didn't take 'free money.'
Rebates Foregone: โˆ’$24M over 3 yearsPrice Increase Avoided: +$45M (used optionality)Long-term Position: Multi-CM, leverage preserved

Related concepts

Keep connecting.

The concepts that orbit this one โ€” each one sharpens the others.

Beyond the concept

Turn Contract Manufacturing Strategy into a live operating decision.

Use this concept as the framing layer, then move into a diagnostic if it maps directly to a current bottleneck.

Typical response time: 24h ยท No retainer required

Turn Contract Manufacturing Strategy into a live operating decision.

Use Contract Manufacturing Strategy as the framing layer, then move into diagnostics or advisory if this maps directly to a current business bottleneck.